A stampede of recent clinical studies suggests that we are on the cusp of developing well-tolerated, orally delivered drugs that can effectively eradicate hepatitis C virus from most, if not all, infected individuals.
This is a preview of subscription content, log in via an institution to check access.
References
Prince, A. M. et al. Lancet 2, 241–246 (1974).
Alter, H. J. et al. Lancet 2, 838–841 (1975).
Choo, Q. L. et al. Science 244, 359–362 (1989).
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D. & Wiersma, S. T. Hepatology 57, 1333–1342 (2013).
Feld, J. J. et al. N. Engl. J. Med. 370, 1594–1603 (2014).
Afdhal, N. et al. N. Engl. J. Med. 370, 1889–1898 (2014).
Afdhal, N. et al. N. Engl. J. Med. 370, 1483–1493 (2014).
Kowdley, K. V. et al. N. Engl. J. Med. 370, 222–232 (2014).
Kowdley, K. V. et al. N. Engl. J. Med. 370, 1879–1888 (2014).
Zeuzem, S. et al. N. Engl. J. Med. 370, 1604–1614 (2014).
Sulkowski, M. S., Jacobson, I. M. & Nelson, D. R. N. Engl. J. Med. 370, 1560–1561 (2014).
Heim, M. H. Nature Rev. Immunol. 13, 535–542 (2013).
Lawitz, E. et al. N. Engl. J. Med. 368, 1878–1887 (2013).
Denniston, M. M., Klevens, R. M., McQuillan, G. M. & Jiles, R. B. Hepatology 55, 1652–1661 (2012).
Dore, G. J., Ward, J. & Thursz, M. J. Viral Hepat. 21 (suppl. 1) 1–4 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rice, C., Saeed, M. Treatment triumphs. Nature 510, 43–44 (2014). https://doi.org/10.1038/510043a
Published:
Issue Date:
DOI: https://doi.org/10.1038/510043a
- Springer Nature Limited
This article is cited by
-
Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment
BMC Infectious Diseases (2020)
-
Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development
Medical Microbiology and Immunology (2019)